Related Experiment Video
Updated: Jul 8, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
An E2F1-dependent gene expression program that determines the balance between proliferation and cell death
Timothy C Hallstrom1, Seiichi Mori, Joseph R Nevins
1Department of Pediatrics, Hematology and Oncology, University of Minnesota, Minneapolis, MN 55455, USA.
Abstract:
The Rb/E2F pathway regulates the expression of genes essential for cell proliferation but that also trigger apoptosis. During normal proliferation, PI3K/Akt signaling blocks E2F1-induced apoptosis, thus serving to balance proliferation and death. We now identify a subset of E2F1 target genes that are specifically repressed by PI3K/Akt signaling, thus distinguishing the E2F1 proliferative or apoptotic function. RNAi-mediated inhibition of several of these PI3K-repressed E2F1 target genes, including AMPK alpha 2, impairs apoptotic induction by E2F1. Activation of AMPK alpha 2 with an AMP analog further stimulates E2F1-induced apoptosis. We also show that the presence of the E2F1 apoptotic expression program in breast and ovarian tumors coincides with good prognosis, emphasizing the importance of the balance in the E2F1 proliferation/apoptotic program.
Insights
The PI3K/Akt pathway balances cell proliferation and apoptosis by repressing specific E2F1 target genes. Inhibiting these genes, like AMPK alpha 2, impairs E2F1-induced apoptosis, impacting cancer prognosis.
Area of Science:
- Molecular Biology
- Cellular Signaling
- Cancer Research
Background:
- The Rb/E2F pathway controls genes for cell proliferation and apoptosis.
- Phosphoinositide 3-kinase (PI3K)/Akt signaling normally inhibits E2F1-induced apoptosis to balance cell division and death.
Purpose of the Study:
- To identify E2F1 target genes specifically repressed by PI3K/Akt signaling.
- To elucidate the role of these genes in distinguishing E2F1's proliferative versus apoptotic functions.
Main Methods:
- RNA interference (RNAi) to inhibit E2F1 target genes.
- Utilizing an AMP analog to activate AMPK alpha 2.
- Analyzing gene expression programs in breast and ovarian tumors.
Main Results:
- Identified E2F1 target genes repressed by PI3K/Akt signaling.
- RNAi-mediated inhibition of genes like AMPK alpha 2 impaired E2F1-induced apoptosis.
- Activation of AMPK alpha 2 enhanced E2F1-induced apoptosis.
Conclusions:
- PI3K/Akt signaling differentiates E2F1's proliferative and apoptotic roles by repressing specific target genes.
- The E2F1 apoptotic program in tumors correlates with favorable prognosis, highlighting the importance of proliferation/apoptosis balance.
Related Concept Videos
Negative Regulator Molecules
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Abnormal Proliferation
Mitogens and the Cell Cycle
Mitogens and the Cell Cycle
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...

